Physicochemical Properties
| Molecular Formula | C19H16BRNO2 |
| Molecular Weight | 370.246 |
| Exact Mass | 369.036 |
| CAS # | 1161002-05-6 |
| PubChem CID | 7433743 |
| Appearance | White to off-white solid powder |
| Density | 1.5±0.1 g/cm3 |
| Boiling Point | 462.7±45.0 °C at 760 mmHg |
| Flash Point | 233.7±28.7 °C |
| Vapour Pressure | 0.0±1.1 mmHg at 25°C |
| Index of Refraction | 1.649 |
| LogP | 4.49 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Heavy Atom Count | 23 |
| Complexity | 484 |
| Defined Atom Stereocenter Count | 3 |
| SMILES | C1C=C[C@@H]2[C@H]1[C@@H](NC3=CC=CC=C23)C4=CC5=C(C=C4Br)OCO5 |
| InChi Key | YOLTZIVRJAPVPH-MJLGCCKJSA-N |
| InChi Code | InChI=1S/C19H16BrNO2/c20-15-9-18-17(22-10-23-18)8-14(15)19-13-6-3-5-11(13)12-4-1-2-7-16(12)21-19/h1-5,7-9,11,13,19,21H,6,10H2/t11-,13-,19+/m0/s1 |
| Chemical Name | (3aS,4R,9bR)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline |
| Synonyms | G 15; G15; G-15 |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | A549 and H1793 cell lines' GPER-mediated proliferation is inhibited by G15 (0.1–10 μM; 2 days) in response to 17β-estradiol (E2) [1]. G15 inhibits H1793 and A549 cell lines at 1 μM for 48 hours. |
| ln Vivo | In formate-induced adenocarcinoma inflammation, G15 (1.46 mg/kg; ih; twice weekly for 14 weeks) decreases the increased nodule number and tumor index in E2 or G1 group tumors [1]. |
| Cell Assay |
Cell proliferation assay [1] Cell Types: A549, H1793 cell lines Tested Concentrations: 0.1, 1, 10μM (combined with 10nM E2) Incubation Duration: 2 days Experimental Results: Inhibition of GPER reaction. -E2 stimulus-mediated proliferation. Western Blot Analysis [1] Cell Types: A549, H1793 cell lines Tested Concentrations: 1 μM (combined with 10 nM E2 and 10 nM G1) Incubation Duration: 48 hrs (hours) Experimental Results: Inhibition of E2 and G1 stimulated GPER responses. |
| Animal Protocol |
Animal/Disease Models: 4weeks old female Kunming mice (urethane-induced adenocarcinoma) [1] Doses: 1.46 mg/kg (combined with E2, 0.09 mg/kg and Fulvestrant (Ful), 2.4 mg/kg ) Method of Route of Administration: subcutaneous injection; twice a week for 14 weeks. Experimental Results: The number of tumor nodules in the E2+Ful+G15 group was diminished. |
| References |
[1]. G-Protein-Coupled Estrogen Receptor Antagonist G15 Decreases Estrogen-Induced Development of Non-Small Cell Lung Cancer. Oncol Res. 2019 Feb 21;27(3):283-292. [2]. Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER. Front Endocrinol (Lausanne). 2019 Jan 9;9:781. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~41.67 mg/mL (~112.55 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (5.62 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (5.62 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.7009 mL | 13.5044 mL | 27.0088 mL | |
| 5 mM | 0.5402 mL | 2.7009 mL | 5.4018 mL | |
| 10 mM | 0.2701 mL | 1.3504 mL | 2.7009 mL |